Tripuraneni Radhika
SEC insider (Form 3/4/5 filer). CIK 0001761114. Chief Medical Officer at Viridian Therapeutics, Inc.\DE (VRDN) and 1 other issuer. 14 reported Form 4/5 transactions since Sep 2024; latest on Aug 14, 2026. Located in WALTHAM, MA.
Companies Tripuraneni Radhika has filed insider reports for
- Viridian Therapeutics, Inc.\DE (VRDN): Officer, Chief Medical Officer
- Terns Pharmaceuticals, Inc. (TERN): Director
Tripuraneni Radhika
CIK: 0001761114
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Aug 14, 2026VRDN
Viridian Therapeutics, Inc.\DE
ExerciseDirect40K shares at avg. $13.21$528K - May 5, 2026TERN
Terns Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
10.7K shares- - May 5, 2026TERN
Terns Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
64K shares- - May 5, 2026TERN
Terns Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
45K shares- - May 5, 2026TERN
Terns Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
4.7K shares- - May 5, 2026TERN
Terns Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
32K shares- - May 5, 2026TERN
Terns Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
32K shares- - May 5, 2026TERN
Terns Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
1.7K shares- - Mar 2, 2026VRDN
Viridian Therapeutics, Inc.\DE
AwardDirectStock Option (Right to Buy)
95.8K shares- - Mar 2, 2026VRDN
Viridian Therapeutics, Inc.\DE
AwardDirectRestricted Stock Units
19.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 14, 2026 |  VRDN Viridian Therapeutics, Inc.\DE | Exercise | 40,000 | $13.21 | $528,400 | Direct |
| May 5, 2026 |  TERN Terns Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 10,657 | - | - | Direct |
| May 5, 2026 | TERN Terns Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 64,000 | - | - | Direct |
| May 5, 2026 | TERN Terns Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 45,000 | - | - | Direct |
| May 5, 2026 | TERN Terns Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 4,676 | - | - | Direct |
| May 5, 2026 | TERN Terns Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 32,000 | - | - | Direct |
| May 5, 2026 | TERN Terns Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 32,000 | - | - | Direct |
| May 5, 2026 | TERN Terns Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 1,697 | - | - | Direct |
| Mar 2, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Award Stock Option (Right to Buy) | 95,800 | - | - | Direct |
| Mar 2, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Award Restricted Stock Units | 19,150 | - | - | Direct |
1-10 of 14 transactions